Vir Biotechnology

GSK and Vir turn to US for distribution as Covid-19 mAb treatment nears blockbuster status
Endpoints
Mon, 10/11/21 - 09:50 pm
GSK
Vir Biotechnology
COVID-19
monoclonal antibodies
The sellside’s most controversial products
EP Vantage
Tue, 08/31/21 - 10:54 am
Merck
Keytruda
Biogen
Aduhelm
Pfizer
Vir Biotechnology
GSK, Vir build case for COVID-19 antibody drug with new study data
BioPharma Dive
Mon, 06/21/21 - 10:07 pm
GSK
Vir Biotechnology
COVID-19
clinical trials
antibodies
FDA authorizes Vir-GSK antibody as variants threaten Eli Lilly mAb
Endpoints
Wed, 05/26/21 - 11:42 pm
GSK
Vir Biotechnology
Eli Lilly
COVID-19
FDA
monoclonal antibodies
Eli Lilly, GlaxoSmithKline-Vir release positive but difficult-to-interpret combo antibody data
Endpoints
Mon, 03/29/21 - 10:52 am
Eli Lilly
GSK
Vir Biotechnology
VIR-7831
bamlanivimab
clinical trials
COVID-19
GlaxoSmithKline and Vir submit Covid-19 mAb for emergency authorization
Endpoints
Fri, 03/26/21 - 10:45 am
GSK
Vir Biotechnology
FDA
COVID-19
Emergency Use Authorization
monoclonal antibodies
Vir, GSK COVID-19 antibody slashes hospitalizations and deaths in phase 3, spurring FDA filing plans
Fierce Biotech
Thu, 03/11/21 - 10:50 am
GSK
Vir Biotechnology
antibodies
FDA
COVID-19
clinical trials
Vir shares tumble after apparent setback for COVID-19 drug
BioPharma Dive
Thu, 03/4/21 - 10:00 am
Vir Biotechnology
GSK
FDA
clinical trials
COVID-19
antibodies
GlaxoSmithKline doubles down on Vir pact, throwing in $345M upfront to go beyond COVID-19
Fierce Biotech
Wed, 02/17/21 - 10:46 am
GSK
Vir Biotechnology
COVID-19
respiratory disease
Vir and GSK Team Up with Eli Lilly for Double Monoclonal Antibody Study
BioSpace
Wed, 01/27/21 - 11:32 am
Vir Biotechnology
Eli Lilly
GSK
VIR-7831
bamlanivimab
COVID-19
Gilead & Vir Announce Collaboration To Find Cure For Hepatitis B Virus
NASDAQ
Tue, 01/12/21 - 11:01 am
Gilead Sciences
Vir Biotechnology
hepatitis B
clinical trials
GlaxoSmithKline, Vir look to succeed where Lilly failed with NIH antibody study in hospitalized Covid-19 patients
Endpoints
Thu, 12/17/20 - 06:25 pm
GSK
Vir Biotechnology
Eli Lilly
antibodies
NIH
COVID-19
clinical trials
Vir Bio’s COVID-19 Antibody Therapy Could be Great, But Will It Be Too Late?
BioSpace
Wed, 11/11/20 - 11:48 pm
Vir Biotechnology
antibodies
COVID-19
Can Either of These Little-Known Biotechs Find New Life Fighting Coronavirus?
Motley Fool
Sun, 10/18/20 - 08:32 pm
Alnylam
Vir Biotechnology
RNAi
vaccines
COVID-19
GSK, Vir cleared to leap into PhIII, angling for a spot in the Covid-19 antibody race led by Lilly, Regeneron
Endpoints
Tue, 10/6/20 - 10:38 am
GSK
Vir Biotechnology
COVID-19
clinical trials
Vir and GlaxoSmithKline begin pivotal study of Covid-19 antibody drug
Stat
Mon, 08/31/20 - 10:11 am
Vir Biotechnology
GSK
clinical trials
antibodies
COVID-19
EASL 2020 – Assembly finds a partner as hepatitis B inches forward
EP Vantage
Fri, 08/28/20 - 10:34 am
EASL
RNAi
hepatitis B
Assembly Biosciences
Abrutus
JNJ
GSK
Vir Biotechnology
Vir enlists Covid-19 antibody rival for cancer, infectious disease discovery work
Endpoints
Mon, 08/24/20 - 10:43 am
Vir Biotechnology
Harbor BioMed
cancer
infectious diseases
Alnylam, Vir plan year-end trial of new RNAi COVID-19 antiviral
Fierce Biotech
Mon, 05/4/20 - 10:37 am
Alnylam
Vir Biotechnology
COVID-19
RNAi
clinical trials
Vir reminds biopharma its original aim is hepatitis B
BioPharma Dive
Thu, 04/16/20 - 11:41 pm
Vir Biotechnology
hepatitis B
VIR-2218
clinical trials

Pages